The platform itself does not prescribe medications or make clinical decisions
() ,
Doctors have always used medications off label, meaning we use certain medications to treat conditions for which the FDA has not approved the drug
The shocking results While comparing the two groups, they found that patients taking a GLP-1 medication had up to a 29% higher risk of developing a chronic cough within the first five years of treatment
Infused with Nicotinamide Adenine Dinucleotide (NAD), this treatment enhances energy levels, promotes cellular repair, and supports overall well-being
The approval of Mounjaro is an exciting step forward for people living with type 2 diabetes given the results seen in these clinical trials. Patrick Archdeacon, MD, associate director of the Division of Diabetes, Lipid Disorders and Obesity within the FDAs Center for Drug Evaluation and Research, also commented on the approval in an agency statement